Browse diseases

…ients with fibrosis by imaging (p < 0.001) and prior/coexistent cancer (p=0.01), shown in table 1. As of last follow-up, the significa…

…nical stratification and prognostic evaluation of patients with systemic sclerosis (SSc). Hallmark SSc antibodies such as anti-topoisomerase (ATA) anti-…

…Introduction Systemic sclerosis (SSc) is characterized by complex autoantibody profiles and variable …

…ical, serological and disease-related features in patients with systemic sclerosis (SSc), according to the presence of anti-SSA, anti-SSB and anti…

…Introduction Interstitial lung disease (ILD) is one of severe manifestations of systemic sclerosis (SSc) and…

…n Antinuclear autoantibodies (ANA) are significant hallmarks of systemic sclerosis (SSc), but their role in pathogenesis is uncertain. Purified IgG from…

…Introduction Systemic sclerosis (SSc) is characterized by three major mechanisms: immune dysregulatio…

…Introduction Systemic sclerosis (SSc) is an autoimmune disease marked by microvascular injury, immune…

…giectasia score and clinically relevant outcomes in SSc, namely pulmonary hypertension, interstitial lung disease (ILD), digital ulcers, and mortality…

…in SSc, which are critically involved in the pathophysiology of SSc-associated interstitial lung disease.…

…isease (ILD) is the leading cause of morbidity and mortality in Systemic Sclerosis (SSc). Nintedanib has been shown to reduce the rate of functional dec…

…Introduction Interstitial lung disease (ILD) is a leading cause of morbidity and mortality in systemic scler…